A fugitive who was discovered to have worked under an alias in the biotech industry has raised questions about how companies hired him despite his criminal history.
Challenges in the electrophysiology and Watchman businesses led Boston Scientific to cut its sales and earnings per share forecasts for the second quarter in a row.
Novo Nordisk sued Eli Lilly for allegedly running a 'deceptive' ad campaign that uses outdated clinical trials to make its obesity and diabetes drugs appear more effective.
ResMed will sell its MatrixCare business for $490 million to private equity firm Frazier Healthcare Partners, according to a press release on July 8, 2026.
Vertex Pharmaceuticals has announced its plan to acquire Crinetics Pharmaceuticals for $10 billion, with the deal expected to close in the coming months.